Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans

Vascular Medicine and Atherosclerosis Unit, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

OBJECTIVES: This investigation sought to determine whether endothelium-derived nitric oxide contributes to hypoxia-induced systemic vasodilation and pulmonary vasoconstriction in humans. BACKGROUND: Endothelium-derived nitric oxide contributes to basal systemic and pulmonary vascular resistance. During hypoxia, systemic vasodilation and pulmonary vasoconstriction occur. There are some data indicating that endothelium-derived nitric oxide mediates changes in vascular resistance during hypoxia, but much of it is contradictory, and none has been derived from normal humans. METHODS: The hemodynamic effects of NG-monomethyl-L-arginine (L-NMMA), a nitric oxide synthase inhibitor, were studied in healthy volunteers under normoxic and hypoxic conditions. A Swan-Ganz catheter and radial artery cannula were inserted to measure right atrial, pulmonary artery, pulmonary capillary wedge and systemic blood pressures. Cardiac output was measured by thermodilution. Systemic vascular resistance and pulmonary vascular resistance were calculated. The pharmacokinetics of L-NMMA (300 mg intravenously) was studied during normoxia in six subjects. Hypoxia was induced in eight subjects who inspired a mixture of nitrogen and oxygen through a gas blender adjusted to reduce the partial pressure of oxygen from (mean +/- SE) 98 +/- 4 to 48 +/- 1 mm Hg. RESULTS: During normoxia, L-NMMA increased systemic vascular resistance from 1,108 +/- 74 to 1,705 +/- 87 dynes-s-cm-5 and increased pulmonary vascular resistance from 60 +/- 5 to 115 +/- 9 dynes-s-cm-5 (p < or = 0.01 for each). Peak effects occurred within 10 min of L-NMMA administration. Acute hypoxia alone decreased systemic vascular resistance from 1,209 +/- 78 to 992 +/- 58 dynes-s-cm-5 (p < or = 0.05) and increased pulmonary vascular resistance from 92 +/- 11 to 136 +/- 4 dynes-s-cm-5 (p < or = 0.01). While hypoxic conditions were maintained, infusion of L-NMMA increased systemic vascular resistance (to 1,496 +/- 97 dynes-s-cm-5, p < or = 0.01) and increased pulmonary vascular resistance further (to 217 +/- 25 dynes-s-cm-5, p < or = 0.01). CONCLUSIONS: Endothelium-derived nitric oxide contributes to systemic vasodilation and serves as a counterregulatory mechanism to attenuate pulmonary vasoconstriction during acute hypoxia in healthy human subjects.

This article has been cited by other articles:

				S. R. Hopkins, A. Kleinsasser, S. Bernard, A. Loeckinger, E. Falor, B. Neradilek, N. L. Polissar, and M. P. Hlastala Hypoxia has a greater effect than exercise on the redistribution of pulmonary blood flow in swine J Appl Physiol, December 1, 2007; 103(6): 2112 - 2119. [Abstract] [Full Text] [PDF]

				A. J. Thomson, G. B. Drummond, W. S. Waring, D. J. Webb, and S. R. J. Maxwell Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function J Appl Physiol, September 1, 2006; 101(3): 809 - 816. [Abstract] [Full Text] [PDF]

				B. D. Hoit, N. D. Dalton, S. C. Erzurum, D. Laskowski, K. P. Strohl, and C. M. Beall Nitric oxide and cardiopulmonary hemodynamics in Tibetan highlanders J Appl Physiol, November 1, 2005; 99(5): 1796 - 1801. [Abstract] [Full Text] [PDF]

				F. M. Mo and H. J. Ballard Acute systemic hypoxia elevates venous but not interstitial potassium of dog skeletal muscle Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1710 - H1718. [Abstract] [Full Text] [PDF]

				M. M. Berger, C. Hesse, C. Dehnert, H. Siedler, P. Kleinbongard, H. J. Bardenheuer, M. Kelm, P. Bartsch, and W. E. Haefeli Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 763 - 767. [Abstract] [Full Text] [PDF]

				R. R. Martinez, S. Setty, P. Zong, J. D. Tune, and H. F. Downey Nitric oxide contributes to right coronary vasodilation during systemic hypoxia Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1139 - H1146. [Abstract] [Full Text] [PDF]

				S. A. Gupte, E. A. Zias, M. R. Sarabu, and M. S. Wolin Role of Prostaglandins in Mediating Differences in Human Internal Mammary and Radial Artery Relaxation Elicited by Hypoxia J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 510 - 518. [Abstract] [Full Text] [PDF]

				S. Olson, R. Oeckler, X. Li, L. Du, F. Traganos, X. Zhao, and T. Burke-Wolin Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L559 - L568. [Abstract] [Full Text] [PDF]

				R. Tamisier, D. Norman, A. Anand, Y. Choi, and J. W. Weiss Evidence of sustained forearm vasodilatation after brief isocapnic hypoxia J Appl Physiol, May 1, 2004; 96(5): 1782 - 1787. [Abstract] [Full Text] [PDF]

				J. A. S. Barreto-Filho, F. M. Consolim-Colombo, G. M. Guerra-Riccio, R. D. Santos, A. P. Chacra, H. F. Lopes, S. H. Teixeira, T. Martinez, J. E. Krieger, and E. M. Krieger Hypercholesterolemia Blunts Forearm Vasorelaxation and Enhances the Pressor Response During Acute Systemic Hypoxia Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1660 - 1666. [Abstract] [Full Text] [PDF]

				W. Johnson, A. Nohria, L. Garrett, J. C. Fang, J. Igo, M. Katai, P. Ganz, and M. A. Creager Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H568 - H575. [Abstract] [Full Text] [PDF]

				J. A. Soares Barreto-Filho, F. M. Consolim-Colombo, H. Ferreira Lopes, C. R. Martins Sobrinho, G. M. Guerra-Riccio, and E. M. Krieger Dysregulation of Peripheral and Central Chemoreflex Responses in Chagas' Heart Disease Patients Without Heart Failure Circulation, October 9, 2001; 104(15): 1792 - 1798. [Abstract] [Full Text] [PDF]

				J-C. Schneider, I. Blazy, M. Dechaux, D. Rabier, N.P. Mason, and J-P. Richalet Response of nitric oxide pathway to l-arginine infusion at the altitude of 4,350 m Eur. Respir. J., August 1, 2001; 18(2): 286 - 292. [Abstract] [Full Text] [PDF]

				T. BUSCH, P. BÄRTSCH, D. PAPPERT, E. GRÜNIG, W. HILDEBRANDT, H. ELSER, K. J. FALKE, and E. R. SWENSON Hypoxia Decreases Exhaled Nitric Oxide in Mountaineers Susceptible to High-Altitude Pulmonary Edema Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 368 - 373. [Abstract] [Full Text]

				S. H. Launois, N. Averill, J. H. Abraham, D. A. Kirby, and J. W. Weiss Cardiovascular responses to nonrespiratory and respiratory arousals in a porcine model J Appl Physiol, January 1, 2001; 90(1): 114 - 120. [Abstract] [Full Text] [PDF]

				M. S. M. IP, B. LAM, L.-Y. CHAN, L. ZHENG, K. W. T. TSANG, P. C. W. FUNG, and W.-K. LAM Circulating Nitric Oxide Is Suppressed in Obstructive Sleep Apnea and Is Reversed by Nasal Continuous Positive Airway Pressure Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2166 - 2171. [Abstract] [Full Text]

				D. L. Moraes, W. S. Colucci, and M. M. Givertz Secondary Pulmonary Hypertension in Chronic Heart Failure : The Role of the Endothelium in Pathophysiology and Management Circulation, October 3, 2000; 102(14): 1718 - 1723. [Abstract] [Full Text] [PDF]

				V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF]

				D. Zhu, E. K. Birks, C. A. Dawson, M. Patel, J. R. Falck, K. Presberg, R. J. Roman, and E. R. Jacobs Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1526 - H1533. [Abstract] [Full Text] [PDF]

				M. Ashina, L. Bendtsen, R. Jensen, L. H. Lassen, F. Sakai, and J. Olesen Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache Brain, September 1, 1999; 122(9): 1629 - 1635. [Abstract] [Full Text] [PDF]

				C. M. Hart Nitric Oxide in Adult Lung Disease Chest, May 1, 1999; 115(5): 1407 - 1417. [Abstract] [Full Text] [PDF]

				M. T. GLADWIN, A. N. SCHECHTER, J. H. SHELHAMER, and F. P. OGNIBENE The Acute Chest Syndrome in Sickle Cell Disease . Possible Role of Nitric Oxide in Its Pathophysiology and Treatment Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1368 - 1376. [Full Text] [PDF]

				M. LEEMAN, V. Z. de BEYL, D. BIARENT, M. MAGGIORINI, C. MELOT, and R. NAEIJE Inhibition of Cyclooxygenase and Nitric Oxide Synthase in Hypoxic Vasoconstriction and Oleic Acid-Induced Lung Injury Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1383 - 1390. [Abstract] [Full Text] [PDF]

				F. T. KANEKO, A. C. ARROLIGA, R. A. DWEIK, S. A. COMHAIR, D. LASKOWSKI, R. OPPEDISANO, M. J. THOMASSEN, and S. C. ERZURUM Biochemical Reaction Products of Nitric Oxide as Quantitative Markers of Primary Pulmonary Hypertension Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 917 - 923. [Abstract] [Full Text] [PDF]

				J. Zanzinger, J. Czachurski, and H. Seller Nitric oxide in the ventrolateral medulla regulates sympathetic responses to systemic hypoxia in pigs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R33 - R39. [Abstract] [Full Text] [PDF]

				S. DEEM, E. R. SWENSON, M. K. ALBERTS, R. G. HEDGES, and M. J. BISHOP Red-Blood-Cell Augmentation of Hypoxic Pulmonary Vasoconstriction . Hematocrit Dependence and the Importance of Nitric Oxide Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1181 - 1186. [Abstract] [Full Text] [PDF]

				M. J. Joyner and N. M. Dietz Nitric oxide and vasodilation in human limbs J Appl Physiol, December 1, 1997; 83(6): 1785 - 1796. [Abstract] [Full Text] [PDF]